Basic Information
| RNALocate ID: | RLID:01001845 |
| RNA Symbol: | hsa-miR-185-5p |
| Localization: | Nucleus |
RNA Information
| RNA Name: | hsa-miR-185 |
| RNA ID: | miRBase:MIMAT0000455 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001842 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001843 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001844 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:11001942 | Exosome | Plasma | 29130611 |
| RLID:11001943 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001944 | Exosome | Breast milk | 22211110 |
| RLID:11001945 | Exosome | Brain tissue | 23382797 |
| RLID:11001946 | Exosome | Plasma | 23663360 |
| RLID:11001947 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001948 | Exosome | Serum | 25135963 |
| RLID:11001949 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001950 | Microvesicle | Plasma | 23077538 |
| RLID:11001951 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001952 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000100 | Exosome | Blood|Tongue tissue | |
| RLID-D:11000383 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-185-5p | Idiopathic pulmonary fibrosis | MNDR-E-MI-20977 |
| MNDR | hsa-miR-185-5p | Medulloblastoma | MNDR-E-MI-20978 |
| MNDR | hsa-miR-185-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-20979 |
| MNDR | hsa-miR-185-5p | Lymphoma | MNDR-E-MI-20980 |
| MNDR | hsa-miR-185-5p | Cutaneous t cell lymphoma | MNDR-E-MI-20981 |
| MNDR | hsa-miR-185-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-20982 |
| MNDR | hsa-miR-185-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-20983 |
| MNDR | hsa-miR-185-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-20984 |
| MNDR | hsa-miR-185-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-20985 |
| MNDR | hsa-miR-185-5p | Her2-receptor positive breast cancer | MNDR-E-MI-20986 |
| MNDR | hsa-miR-185-5p | Breast cancer luminal | MNDR-E-MI-20987 |
| MNDR | hsa-miR-185-5p | Anencephaly | MNDR-E-MI-20988 |
| MNDR | hsa-miR-185-5p | Neurofibromatosis 1 | MNDR-E-MI-20989 |
| MNDR | hsa-miR-185-5p | Prostate cancer | MNDR-E-MI-20990 |
| MNDR | hsa-miR-185-5p | Prostate carcinoma | MNDR-E-MI-20991 |
| MNDR | hsa-miR-185-5p | Gastric cancer | MNDR-E-MI-20992 |
| MNDR | hsa-miR-185-5p | Wolfram syndrome | MNDR-E-MI-20993 |
| MNDR | hsa-miR-185-5p | Alzheimer disease | MNDR-E-MI-20994 |
| MNDR | hsa-miR-185-5p | Intracranial aneurysm | MNDR-E-MI-20995 |
| MNDR | hsa-miR-185-5p | Esophageal carcinoma | MNDR-E-MI-20996 |
| MNDR | hsa-miR-185-5p | Dysautonomia familial | MNDR-E-MI-20997 |
| MNDR | hsa-miR-185-5p | Polycystic ovary syndrome | MNDR-E-MI-20998 |
| MNDR | hsa-miR-185-5p | Head and neck cancer | MNDR-E-MI-20999 |
| MNDR | hsa-miR-185-5p | Cardiovascular disease | MNDR-E-MI-21000 |
| MNDR | hsa-miR-185-5p | Moyamoya disease | MNDR-E-MI-21001 |
| MNDR | hsa-miR-185-5p | Lung cancer | MNDR-E-MI-21002 |
| MNDR | hsa-miR-185-5p | Parkinson disease | MNDR-E-MI-21003 |
| MNDR | hsa-miR-185-5p | Breast cancer | MNDR-E-MI-21004 |
| MNDR | hsa-miR-185-5p | Pituitary neoplasms | MNDR-E-MI-21005 |
| MNDR | hsa-miR-185-5p | Pancreatic cancer | MNDR-E-MI-21006 |
| MNDR | hsa-miR-185-5p | Malignant melanoma | MNDR-E-MI-21007 |
| MNDR | hsa-miR-185-5p | Rectum adenocarcinoma | MNDR-E-MI-21008 |
| MNDR | hsa-miR-185-5p | Nephroblastoma | MNDR-E-MI-21009 |
| MNDR | hsa-miR-185-5p | Colon cancer | MNDR-E-MI-21010 |
| MNDR | hsa-miR-185-5p | Colon adenocarcinoma | MNDR-E-MI-21011 |
| MNDR | hsa-miR-185-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-21012 |
| MNDR | hsa-miR-185-5p | Ovarian cancer | MNDR-E-MI-21013 |
| MNDR | hsa-miR-185-5p | Acromegaly | MNDR-E-MI-21014 |
| MNDR | hsa-miR-185-5p | Carcinoma ductal breast | MNDR-E-MI-21015 |
| MNDR | hsa-miR-185-5p | Glioblastoma | MNDR-E-MI-21016 |
| MNDR | hsa-miR-185-5p | Glioma | MNDR-E-MI-21017 |
| MNDR | hsa-miR-185-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-21018 |
| MNDR | hsa-miR-185-5p | Chordoma | MNDR-E-MI-21019 |
| MNDR | hsa-miR-185-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-21020 |
| MNDR | hsa-miR-185-5p | Osteosarcoma | MNDR-E-MI-21021 |
| MNDR | hsa-miR-185-5p | Liposarcoma | MNDR-E-MI-21022 |
| MNDR | hsa-miR-185-5p | Meningioma | MNDR-E-MI-21023 |
| MNDR | hsa-miR-185-5p | Liver cancer | MNDR-E-MI-21024 |
| MNDR | hsa-miR-185-5p | Uterine cancer | MNDR-E-MI-21025 |
| MNDR | hsa-miR-185-5p | Cervical adenocarcinoma | MNDR-E-MI-21026 |
| MNDR | hsa-miR-185-5p | Gastric adenocarcinoma | MNDR-E-MI-21027 |
| MNDR | hsa-miR-185-5p | Cervical squamous cell carcinoma | MNDR-E-MI-21028 |
| MNDR | hsa-miR-185-5p | Pituitary adenoma | MNDR-E-MI-21029 |
| MNDR | hsa-miR-185-5p | Lung squamous cell carcinoma | MNDR-E-MI-21030 |
| MNDR | hsa-miR-185-5p | Non-small cell lung cancer | MNDR-E-MI-21031 |
| MNDR | hsa-miR-185-5p | Lung adenocarcinoma | MNDR-E-MI-21032 |
| MNDR | hsa-miR-185-5p | Thyroid carcinoma | MNDR-E-MI-21033 |
| MNDR | hsa-miR-185-5p | Bladder urothelial carcinoma | MNDR-E-MI-21034 |
| MNDR | hsa-miR-185-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-21035 |
| MNDR | hsa-miR-185-5p | Carcinoma renal cell | MNDR-E-MI-21036 |
| MNDR | hsa-miR-185-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-21037 |
| MNDR | hsa-miR-185-5p | Clear cell renal cell carcinoma | MNDR-E-MI-21038 |
| MNDR | hsa-miR-185-5p | Chromophobe renal cell carcinoma | MNDR-E-MI-21039 |
| MNDR | hsa-miR-185-5p | Large cell carcinoma | MNDR-E-MI-21040 |
| MNDR | hsa-miR-185-5p | Esophageal cancer | MNDR-E-MI-21041 |
| MNDR | hsa-miR-185-5p | Liver cirrhosis | MNDR-E-MI-21042 |
| MNDR | hsa-miR-185-5p | Oncocytoma | MNDR-E-MI-21043 |
| MNDR | hsa-miR-185-5p | Stomach carcinoma | MNDR-E-MI-21044 |
| MNDR | hsa-miR-185-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-21045 |
| MNDR | hsa-miR-185-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-21046 |
| MNDR | hsa-miR-185-5p | Fibromyalgia | MNDR-E-MI-21047 |
| MNDR | hsa-miR-185-5p | Encephalomyelitis | MNDR-E-MI-21048 |
| MNDR | hsa-miR-185-5p | Breast invasive carcinoma | MNDR-E-MI-21049 |
| MNDR | hsa-miR-185-5p | Early hepatocellular carcinoma | MNDR-E-MI-21050 |
| MNDR | hsa-miR-185-5p | Malignant pleural mesothelioma | MNDR-E-MI-21051 |
| MNDR | hsa-miR-185-5p | Retinoblastoma | MNDR-E-MI-21052 |
| MNDR | hsa-miR-185-5p | Neuroblastoma | MNDR-E-MI-21053 |
| MNDR | hsa-miR-185-5p | Hodgkin lymphoma | MNDR-E-MI-21054 |
| MNDR | hsa-miR-185-5p | Dementia vascular | MNDR-E-MI-21055 |
| MNDR | hsa-miR-185-5p | Tonsil cancer | MNDR-E-MI-21056 |
| MNDR | hsa-miR-185-5p | Psoriasis | MNDR-E-MI-21057 |
| MNDR | hsa-miR-185-5p | Acute myelocytic leukemia | MNDR-E-MI-21058 |
| MNDR | hsa-miR-185-5p | Colorectal cancer | MNDR-E-MI-21059 |
| MNDR | hsa-miR-185-5p | Multiple myeloma | MNDR-E-MI-21060 |
| MNDR | hsa-miR-185-5p | Ependymoma | MNDR-E-MI-21061 |
| MNDR | hsa-miR-185-5p | Hearing loss noise-induced | MNDR-E-MI-21062 |
| MNDR | hsa-miR-185-5p | Cardiomegaly | MNDR-E-MI-21063 |
| MNDR | hsa-miR-185-5p | Sleep deprivation | MNDR-E-MI-21064 |
| MNDR | hsa-miR-185-5p | Epstein-barr virus infections | MNDR-E-MI-21065 |
| MNDR | hsa-miR-185-5p | Stroke lacunar | MNDR-E-MI-21066 |
| MNDR | hsa-miR-185-5p | Breast cancer her3+ negative | MNDR-E-MI-21067 |
| MNDR | hsa-miR-185-5p | High grade dysplastic nodule | MNDR-E-MI-21068 |
| MNDR | hsa-miR-185-5p | HPV | MNDR-E-MI-21069 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCG4 | Homo sapiens | RR00024860 |
TOP